Xenin-25 Potentiates Glucose-dependent Insulinotropic Polypeptide Action via a Novel Cholinergic Relay Mechanism
Open Access
- 25 June 2010
- journal article
- Published by Elsevier BV
- Vol. 285 (26), 19842-19853
- https://doi.org/10.1074/jbc.m110.129304
Abstract
No abstract availableThis publication has 79 references indexed in Scilit:
- The Role of Incretins in Glucose Homeostasis and Diabetes TreatmentPharmacological Reviews, 2008
- Central Control of Body Weight and AppetiteJournal of Clinical Endocrinology & Metabolism, 2008
- Targeted Ablation of Glucose-dependent Insulinotropic Polypeptide-producing Cells in Transgenic Mice Reduces Obesity and Insulin Resistance Induced by a High Fat DietJournal of Biological Chemistry, 2008
- Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit productionBlood Cells, Molecules, and Diseases, 2007
- Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapiesCurrent Medical Research and Opinion, 2007
- Use of chromosome substitution strains to identify seizure susceptibility loci in miceMammalian Genome, 2007
- The Physiology of Incretin Hormones and the Basis for DPP-4 InhibitorsThe Diabetes Educator, 2007
- Effects of muscarinic receptor type 3 knockout on mouse islet secretory responsesBiochemical and Biophysical Research Communications, 2004
- Xenin—a novel suppressor of food intake in ratsBrain Research, 1998
- A comparison of the central and peripheral antimuscarinic effects of atropine and methylatropine injected systematically and into the cerebral ventriclesLife Sciences, 1988